Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 GSK and Pharmacopeia Enter Discovery and Development Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

GSK and Pharmacopeia Enter Discovery and Development Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pharmacopeia and GlaxoSmithKline have entered a drug discovery and development alliance. Pharmacopeia and GSK–through its recently established Center of Excellence for External Drug Discovery (CEEDD)–will collaborate to deliver clinically validated therapeutic candidates to GSK’s global R&D organization.

The goal of the alliance is for Pharmacopeia to discover active molecules and bring them to clinical proof of concept, yielding novel candidates in broad therapeutic areas. GSK will have exclusive options to conduct Phase III trials and to commercialize products from the collaboration on a worldwide basis. Pharmacopeia will retain rights to programs for which GSK does not exercise its option.

Under the terms of the agreement, Pharmacopeia will receive $15 million in cash payments from GSK. Also, each drug development program pursued under the alliance will be subject to success-based milestone payments totaling as much as $83 million for a successful program and royalties.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics